QUINAGLUTE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Quinaglute, and what generic alternatives are available?
Quinaglute is a drug marketed by Bayer Hlthcare and is included in one NDA.
The generic ingredient in QUINAGLUTE is quinidine gluconate. There are twenty-seven drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the quinidine gluconate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Quinaglute
A generic version of QUINAGLUTE was approved as quinidine gluconate by SUN PHARM INDUSTRIES on February 11th, 1987.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for QUINAGLUTE?
- What are the global sales for QUINAGLUTE?
- What is Average Wholesale Price for QUINAGLUTE?
Summary for QUINAGLUTE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 104 |
| Patent Applications: | 3,926 |
| DailyMed Link: | QUINAGLUTE at DailyMed |
US Patents and Regulatory Information for QUINAGLUTE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bayer Hlthcare | QUINAGLUTE | quinidine gluconate | TABLET, EXTENDED RELEASE;ORAL | 016647-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
